Corner Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-20.
Corner Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 20, 2025. The filing reports $16.75M sold. Its industry group is Pharmaceuticals. It names Nick Seaver (Executive Officer, Director), Steven Altschuler (Executive Officer, Director), Andrew Bellinger (Director) (SEC Form D, October 20, 2025).
Is this your company?
Sell to companies like Corner Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Corner Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Corner Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Corner Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Corner Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Corner Therapeutics, Inc. →Get the full cited report on Corner Therapeutics, Inc.
What the filing shows about Corner Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Corner Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Corner Therapeutics, Inc.'s address as 300 N. Beacon Street, Building 39, Suite 202, Watertown, MA 02472.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Corner Therapeutics, Inc. See pricing
Corner Therapeutics, Inc. is a registered filer with the SEC (CIK 2019875) and has filed since 2024-04-23. 4 filings are on record, the latest on 2025-10-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Corner Therapeutics, Inc.'s Form D of 2025-10-20 names Nick Seaver, Steven Altschuler, Andrew Bellinger and 5 more as its officers, directors or promoters.
Its new offerings report $67.70M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Nick Seaver is named as Executive Officer and Director on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Steven Altschuler is named as Executive Officer and Director on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Andrew Bellinger is named as Director on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Alan Ezekowitz is named as Director on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Jonathan Kagan is named as Executive Officer and Director on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Richard Malley is named as Director on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Andrew Cornforth is named as Executive Officer on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
Garrett Nichols is named as Executive Officer on the Form D that Corner Therapeutics, Inc. filed with the SEC on 20 October 2025, one of 8 people that filing names.
8 people named on the filing — 5 holding an executive role and 3 as directors only.
Named as of the 2025-10-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Corner Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Corner Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Corner Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Corner Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Corner Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Corner Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/corner-therapeutics-inc-form-d-25000001